March 2022

Groundbreaking work in the fields of neuroscience and endocrinology

Two new ERC Consolidator Grants for Charité researchers

Research at scientific boundaries and awards for excellent work - 313 scientists from 24 European countries are the winners of the latest competition for Consolidator Grants of the European Research Council (ERC), among them two researchers from Charité - Universitätsmedizin Berlin and ECN member.

Read more … Groundbreaking work in the fields of neuroscience and endocrinology

Class II PI3K lipid kinase: Structure of novel drug target resolved

Phosphatidylinositol 3-kinase, or PI3K for short, is a family of lipid kinases that plays a key role in the human body, performing functions such as cell division, metabolism, and cell growth. While class I PI3Kα is well-researched and an important target for cancer drugs, little is known about class II of this lipid kinase family. Now, researchers from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) have been able to shed light on its structure and function.

Read more … Class II PI3K lipid kinase: Structure of novel drug target resolved